AEQUITA PHARMACY recalls Tirzepatide and Niacinamide 11.24 mg + 1.0mg/0.5 mL injection vials due to lack of processing controls. All lots within expiry date are affected.
Lack of Processing Controls.
AEQUITA PHARMACY is recalling Tirzepatide and Niacinamide injections because of a lack of processing controls. This could affect product safety, though the specific risk isn't detailed in the recall notice.
The recall states there was a lack of processing controls, which could lead to product safety issues. However, the exact hazard mechanism isn't specified in the notice.
People who own or use the Tirzepatide and Niacinamide injections from AEQUITA PHARMACY. Those with the specific product details listed in the recall are most at risk.
Check for the product name 'Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol' on the vial. The product is a 2 mL multi-dose vial that requires refrigeration but not freezing.
Identify the product by checking the vial label for the specific name and quantity.
The recall states there was a lack of processing controls, but the specific safety risk isn't detailed in the notice.
The recall does not provide a specific remedy, so no action is required beyond checking the product details.
The recall mentions all lots within expiry date are affected, but no specific lot numbers are listed.
We’ve drafted a message you can send AEQUITA PHARMACY to request your refund or repair — edit it as you like.
Subject: Recall D-0558-2025 — AEQUITA PHARMACY AEQUITA PHARMACY Hello, I own a AEQUITA PHARMACY that is covered by recall D-0558-2025 from AEQUITA PHARMACY. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
